LDL-C does not cause cardiovascular disease: a comprehensive review of the current literature
2018/09/10 by Uffe Ravnskov, Michel de Lorgeril, David M. Diamond +13 · 2 voices · 28 citations
Medicine · Economics, Econometrics and Finance · #Lipoproteins and Cardiovascular Health #Health Systems, Economic Evaluations, Quality of Life #Diabetes, Cardiovascular Risks, and Lipoproteins
paper · pdf · doi:10.1080/17512433.2018.1519391
Abstract
INTRODUCTION: For half a century, a high level of total cholesterol (TC) or low-density lipoprotein cholesterol (LDL-C) has been considered to be the major cause of atherosclerosis and cardiovascular disease (CVD), and statin treatment has been widely promoted for cardiovascular prevention. However, there is an increasing understanding that the mechanisms are more complicated and that statin treatment, in particular when used as primary prevention, is of doubtful benefit. Areas covered: The authors of three large reviews recently published by statin advocates have attempted to validate the current dogma. This article delineates the serious errors in these three reviews as well as other obvious falsifications of the cholesterol hypothesis. Expert commentary: Our search for falsifications of the cholesterol hypothesis confirms that it is unable to satisfy any of the Bradford Hill criteria for causality and that the conclusions of the authors of the three reviews are based on misleading statistics, exclusion of unsuccessful trials and by ignoring numerous contradictory observations.
Citations
Cited by
- Hiding unhealthy heart outcomes in a low-fat diet trial: the Women’s Health Initiative Randomized Controlled Dietary Modification Trial finds that postmenopausal women with established coronary heart disease were at increased risk of an adverse outcome if they consumed a low-fat ‘heart-healthy’ diet
- Statin therapy is not warranted for a person with high LDL-cholesterol on a low-carbohydrate diet
- Randomized crossover trial of a modified ketogenic diet in Alzheimer’s disease
- Cholesterol versus Inflammation as Cause of Chronic Diseases. [europepmc]
- Coagulatory Defects in Type-1 and Type-2 Diabetes. [europepmc]
- Lipid profiles and risk of major adverse cardiovascular events in CKD and diabetes: A nationwide population-based study. [europepmc]
- Dietary Recommendations for Familial Hypercholesterolaemia: an Evidence-Free Zone. [europepmc]
- An Atomic-Level Perspective of HMG-CoA-Reductase: The Target Enzyme to Treat Hypercholesterolemia. [europepmc]
- Cholesterol Homeostasis: An In Silico Investigation into How Aging Disrupts Its Key Hepatic Regulatory Mechanisms. [europepmc]
- Controlling the thickness of the atherosclerotic plaque by statin medication. [europepmc]
- Prevalence and management of hypercholesterolemia in France, the Esteban observational study. [europepmc]
- Exploring the Causal Roles of Circulating Remnant Lipid Profile on Cardiovascular and Cerebrovascular Diseases: Mendelian Randomization Study. [europepmc]
- Total cholesterol, arterial stiffness, and systolic blood pressure: a mediation analysis. [europepmc]
- Randomized crossover trial of a modified ketogenic diet in Alzheimer's disease. [europepmc]
- Translating the dose response into risk and benefit. [europepmc]
- Global prevalence of dyslipidaemia in adult populations: a systematic review protocol. [europepmc]
- Examining the Efficacy of a Very-Low-Carbohydrate Ketogenic Diet on Cardiovascular Health in Adults with Mildly Elevated Low-Density Lipoprotein Cholesterol in an Open-Label Pilot Study. [europepmc]
- Monocyte-to-high-density lipoprotein-cholesterol ratio (MHR) and the risk of all-cause and cardiovascular mortality: a nationwide cohort study in the United States. [europepmc]
- Very Low-Carbohydrate High-Fat Diet Improves Risk Markers for Cardiometabolic Health More Than Exercise in Men and Women With Overfat Constitution: Secondary Analysis of a Randomized Controlled Clinical Trial. [europepmc]
- Importance of Coagulation Factors as Critical Components of Premature Cardiovascular Disease in Familial Hypercholesterolemia. [europepmc]
- Correlation study on serum miR-222-3p and glucose and lipid metabolism in patients with polycystic ovary syndrome. [europepmc]
- Long-term prognostic value of LDL-C, HDL-C, lp(a) and TG levels on cardiovascular disease incidence, by body weight status, dietary habits and lipid-lowering treatment: the ATTICA epidemiological cohort study (2002-2012). [europepmc]
- The LDL-C/ApoB ratio predicts cardiovascular and all-cause mortality in the general population. [europepmc]
- The Ketogenic Diet and Cardiovascular Diseases. [europepmc]
- Reply to Najjar, R.S. Comment on "Dyńka et al. The Ketogenic Diet and Cardiovascular Diseases. Nutrients 2023, 15 , 3368". [europepmc]
- Remnant cholesterol inflammatory index and its association with all-cause and cause-specific mortality in middle-aged and elderly populations: evidence from US and Chinese national population surveys. [europepmc]
- Hiding unhealthy heart outcomes in a low-fat diet trial: the Women's Health Initiative Randomized Controlled Dietary Modification Trial finds that postmenopausal women with established coronary heart disease were at increased risk of an adverse outcome if they consumed a low-fat 'heart-healthy' diet. [europepmc]
- Gut Microbiome: Profound Implications for Diet and Disease. [europepmc]
Discussions
Related